Nianzhi Chen

661 total citations
22 papers, 365 citations indexed

About

Nianzhi Chen is a scholar working on Molecular Biology, Cancer Research and Pharmacology. According to data from OpenAlex, Nianzhi Chen has authored 22 papers receiving a total of 365 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 6 papers in Cancer Research and 5 papers in Pharmacology. Recurrent topics in Nianzhi Chen's work include Berberine and alkaloids research (5 papers), Cancer Mechanisms and Therapy (4 papers) and Cancer-related molecular mechanisms research (4 papers). Nianzhi Chen is often cited by papers focused on Berberine and alkaloids research (5 papers), Cancer Mechanisms and Therapy (4 papers) and Cancer-related molecular mechanisms research (4 papers). Nianzhi Chen collaborates with scholars based in China. Nianzhi Chen's co-authors include Jinhao Zeng, Jianyuan Tang, Maoyuan Zhao, Qiao Zheng, Jianyuan Tang, Xiao Ma, Wenhao Liao, Lu Liu, Xiaolin Xiao and Shiyun Tang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Ethnopharmacology and Frontiers in Pharmacology.

In The Last Decade

Nianzhi Chen

20 papers receiving 360 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nianzhi Chen China 12 158 59 57 56 50 22 365
Minmin Xu China 11 166 1.1× 85 1.4× 56 1.0× 48 0.9× 56 1.1× 22 364
Juan Nie China 11 176 1.1× 59 1.0× 45 0.8× 45 0.8× 30 0.6× 17 406
Mei‐Due Yang Taiwan 12 144 0.9× 61 1.0× 102 1.8× 39 0.7× 40 0.8× 32 353
Yanting You China 13 234 1.5× 57 1.0× 39 0.7× 86 1.5× 36 0.7× 36 517
Xiawen Yang China 14 212 1.3× 48 0.8× 34 0.6× 31 0.6× 51 1.0× 24 458
Haiyan Sun China 8 242 1.5× 54 0.9× 62 1.1× 54 1.0× 42 0.8× 22 519
Bo‐Ram Jin South Korea 14 185 1.2× 49 0.8× 49 0.9× 36 0.6× 19 0.4× 41 442
Prakash Dharmalingam India 10 238 1.5× 64 1.1× 61 1.1× 36 0.6× 20 0.4× 11 417
Zhiyuan Lou China 12 224 1.4× 47 0.8× 55 1.0× 26 0.5× 28 0.6× 28 467
Fengqin Wang China 11 136 0.9× 58 1.0× 33 0.6× 37 0.7× 70 1.4× 31 406

Countries citing papers authored by Nianzhi Chen

Since Specialization
Citations

This map shows the geographic impact of Nianzhi Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nianzhi Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nianzhi Chen more than expected).

Fields of papers citing papers by Nianzhi Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nianzhi Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nianzhi Chen. The network helps show where Nianzhi Chen may publish in the future.

Co-authorship network of co-authors of Nianzhi Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Nianzhi Chen. A scholar is included among the top collaborators of Nianzhi Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nianzhi Chen. Nianzhi Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Fang, Zexu Gu, Qingxia Xu, et al.. (2025). Potential of Glycyrrhiza in the prevention of colitis-associated colon cancer. Fitoterapia. 181. 106398–106398. 4 indexed citations
2.
Chen, Nianzhi, Maoyuan Zhao, Zexu Gu, et al.. (2025). Dehydrodiisoeugenol targets NOD2 exerting dual effects against colitis and colorectal cancer: a double-edged sword. Molecular Medicine. 31(1). 221–221.
3.
Yuan, Yun, Li Liu, Nianzhi Chen, Shiyun Tang, & Yuan Qi. (2025). Shenqi compound ameliorates renal fibrosis in diabetic kidney disease by inhibiting LRG1/TGF-β/Smad signaling pathway. Phytomedicine. 148. 157355–157355.
4.
Liang, Dan, et al.. (2024). Jin-Gui-Shen-Qi Wan alleviates fibrosis in mouse diabetic nephropathy via MHC class II. Journal of Ethnopharmacology. 324. 117745–117745. 8 indexed citations
5.
Zhao, Maoyuan, Yi Yang, Huafeng Pan, et al.. (2024). (-)-Asarinin alleviates gastric precancerous lesions by promoting mitochondrial ROS accumulation and inhibiting the STAT3 signaling pathway. Phytomedicine. 126. 155348–155348. 8 indexed citations
6.
7.
Liu, Lu, Yunjie Zhao, Zhenyi Luo, et al.. (2023). Targeting extracellular matrix through phytochemicals: a promising approach of multi-step actions on the treatment and prevention of cancer. Frontiers in Pharmacology. 14. 1186712–1186712. 17 indexed citations
8.
Liang, Dan, Lu Liu, Maoyuan Zhao, et al.. (2023). Tanshinone I attenuates gastric precancerous lesions by inhibiting epithelial mesenchymal transition through the p38/STAT3 pathway. International Immunopharmacology. 124(Pt A). 110902–110902. 11 indexed citations
9.
Zhu, Yu, Songtao Li, Nianzhi Chen, et al.. (2023). Licochalcone B confers protective effects against LPS-Induced acute lung injury in cells and mice through the Keap1/Nrf2 pathway. Redox Report. 28(1). 2243423–2243423. 20 indexed citations
10.
Liu, Lu, et al.. (2023). Bujing Yishi tablets alleviate photoreceptor cells death via the P2X7R/CX3CL1/CX3CR1 pathway in Retinitis Pigmentosa rats. Phytomedicine. 115. 154828–154828. 5 indexed citations
11.
Wang, Hengyi, et al.. (2023). Purine and purinergic receptors in health and disease. SHILAP Revista de lepidopterología. 4(5). e359–e359. 24 indexed citations
12.
Chen, Nianzhi, Xiao Ma, Xiaolin Xiao, et al.. (2022). Rediscovery of Traditional Plant Medicine: An Underestimated Anticancer Drug of Chelerythrine. Frontiers in Pharmacology. 13. 906301–906301. 34 indexed citations
13.
Tang, Jianyuan, Nianzhi Chen, Jundong Wang, et al.. (2022). Berberine for gastric cancer prevention and treatment: Multi-step actions on the Correa’s cascade underlie its therapeutic effects. Pharmacological Research. 184. 106440–106440. 59 indexed citations
14.
Liao, Wenhao, Yuchen Li, Jing Wang, et al.. (2022). Natural Products-Based Nanoformulations: A New Approach Targeting CSCs to Cancer Therapy. International Journal of Nanomedicine. Volume 17. 4163–4193. 10 indexed citations
15.
Liao, Wenhao, Yueqiang Wen, Jing Wang, et al.. (2022). Gallic acid alleviates gastric precancerous lesions through inhibition of epithelial mesenchymal transition via Wnt/β-catenin signaling pathway. Journal of Ethnopharmacology. 302(Pt A). 115885–115885. 33 indexed citations
16.
Zhao, Maoyuan, Yi Yang, Qing Nian, et al.. (2022). Phytochemicals and mitochondria: Therapeutic allies against gastric cancer. Phytomedicine. 110. 154608–154608. 13 indexed citations
17.
Gao, Ying, Jundong Wang, Maoyuan Zhao, et al.. (2022). Atractylenolide III Attenuates Angiogenesis in Gastric Precancerous Lesions Through the Downregulation of Delta-Like Ligand 4. Frontiers in Pharmacology. 13. 797805–797805. 15 indexed citations
18.
Liao, Wenhao, Lanlan Zhang, Xian Chen, et al.. (2022). Targeting cancer stem cells and signalling pathways through phytochemicals: A promising approach against colorectal cancer. Phytomedicine. 108. 154524–154524. 44 indexed citations
19.
Liu, Lu, Dan Liang, Qiao Zheng, et al.. (2022). Berbamine dihydrochloride suppresses the progression of colorectal cancer via RTKs/Akt axis. Journal of Ethnopharmacology. 303. 116025–116025. 15 indexed citations
20.
Zeng, Jinhao, Xiao Ma, Yu Chen, et al.. (2021). Ginsenoside Rb1 Lessens Gastric Precancerous Lesions by Interfering With β-Catenin/TCF4 Interaction. Frontiers in Pharmacology. 12. 682713–682713. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Minmin Xu Breakdown of academic impact, for papers by Juan Nie Breakdown of academic impact, for papers by Mei‐Due Yang Breakdown of academic impact, for papers by Yanting You Breakdown of academic impact, for papers by Xiawen Yang Breakdown of academic impact, for papers by Haiyan Sun Breakdown of academic impact, for papers by Bo‐Ram Jin Breakdown of academic impact, for papers by Prakash Dharmalingam Breakdown of academic impact, for papers by Zhiyuan Lou Breakdown of academic impact, for papers by Fengqin Wang
Rankless by CCL
2026